Menu

CEL-SCI Corporation CVM

Full chart Compare
Set alert

Price alert · CVM

All alert types
1.35 USD -0.10 (-6.90%)

At closeNov 9, 2026, 5:05 PM EST

1.39 +0.04 +2.96%

After hours · Nov 9, 5:05 PM ET

1.35 Day range 1.53
0.89 52-week range 7.80
YTD
-74.33%
1 year
-80.82%

Discussion (163)

Sign in to join the discussion

alsp@qx.net CVM 2 years ago #41

At this point how can any of you actually have faith in Geert? And where is the BOD?

alsp@qx.net CVM 2 years ago #42

Best way to generate news and perhaps interest in this stock is to fire the CEO and hire someone from an established biotech to getrdun

alsp@qx.net CVM 2 years ago #43

If there is any evidence of efficacy, why do another study when you HAVE proven there is ZERO TOXICITY? Just grant some type of limited approval so patients can be treated. But the FDA is corrupt (what happened to Biden’s cancer moonshot?) and Geert is a tool.

alsp@qx.net CVM 2 years ago #44

It is a special kind of stupid when a biotech CEO has a promising novel cancer treatment with proven efficacy showing ZERO TOXICITY cannot get any kind of approval from a regulatory body.
Where are the lawsuits?

alsp@qx.net CVM 2 years ago #45

What we have with CVM is an inept (or corrupt) CEO who cannot navigate the regulatory agencies (remember, MK has been in trials/development for over 30 years) coupled with a corrupt FDA that is totally beholding to big pharma and basically does its bidding. CVM will be bled dry and acquired by a big player at a huge discount to the $150-$200/s CVM would command with approval.

alsp@qx.net CVM 2 years ago #46

I will repost this for the umpteenth time. The original study DID show - with no concerns - that MK had ZERO TOXICITY! With that established, there is no reason for another trial. The FDA can - and should - give some type of conditional improvement. Phase III trials have 2 purposes - to show that a drug is effective (40% increased 5 year survival seems to do that) and to uncover any side effects missed in the smaller sample sizes (again ZERO toxicity).
What we have with CVM

alsp@qx.net CVM 2 years ago #47

I have posted many times that a drug like MK with ZERO TOXICITY treating a high mortality cancer illness should have received some type of conditional approval after the trial results were published. The FDA is a corrupt organization and Geert has shown nothing but continued ineptness in guiding this company. I dont understand why that there have been no shareholder lawsuits

alsp@qx.net CVM 2 years ago #48

Although the European pediatric clearance does represent at least SOME type of approval, children generally do not get the type of H&N cancer MK treats

alsp@qx.net CVM 2 years ago #49

Finance guy added to BOD. May mean sale of company or liquidation. Would be more optimistic if Geert was in leg irons.
Where is the shareholder lawsuit? Publicly might actually help share price.

alsp@qx.net CVM 2 years ago #50

MK will never be approved by FDA until CVM is bought out at fire sale and then MK submitted by big pharmaceutical company player. It could be insiders aren’t buying bc deal is on table. If CVM was a serious company Geert would have been fired long ago.